![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 31, 2018 5:43:05 AM
Not sure how the pricing will work out. Depends on who we hire and cost to distribute our product if and when approved. We had better pick the best reps that know the field, and have in with the doctor's using the drug, to distribute our product. Take market share fast and don't go cheap there. They will save money of the more effective drug.
I do see the potential of MNTA taking market share from CSL and Baxter if we get approval of a better and more effective product. We will have the patent they don't. Our patents better cover all the drugs we are thinking about getting approved. Shut out the crowd with out patent protection if possible.
Yes, we do need the trials to be positive. CW sure feels like they are going to be positive.
I remember him saying he was going after 84 products at the same time. Well with the big off label usage he is up to 100 before he hits the clinical trial.
Doctor's with very is sick patients have already been going off label and if we get approved just watch how fast they switch if less does better.
Time will tell soon.
Boing X 2
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM